ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation

Pirisinu, Marco; Tin Chanh Pham; Zhang, Daniel Xin; Tran Nguyen Hong; Lap Thi Nguyen; Le, Minh T. N.*河北医科大学
Seminars in Cancer Biology2022-5DOI: 10.1016/j.semcancer.2020.08.007
41被引8阅读
引用收藏
分享

摘要

As cancer poses a significant threat to the well-being of humans on a global scale, many researchers have embarked on the search for effective anticancer therapeutic agents. In recent years, many drugs have been shown to have extraordinary anticancer effects. However, in a lot of cases the treatment is accompanied by undesirable side effects due to some intrinsic properties linked to the therapeutic agents, such as poor targeting selectivity and short half-life in the circulation. In this regard, extracellular vesicles (EVs), a diverse family of natural cell-derived vesicles, steal the show as potential anticancer immunotherapy or delivery vectors of anticancer agents since they are an innate mechanism of intercellular communication. Here, we describe some of the most hotly-debated issues regarding the use of EVs as anticancer therapeutics. First, we review the biology of EVs providing the most up-to-date definition of EVs as well as highlighting their circulation kinetics and homing properties. Next, we share our views on popular methods reported for EV isolation, characterization, and functional analysis. Pioneering and innovative reports along with emerging challenges in the field of EV imaging and EV drug loading strategies are then discussed. Finally, we examine in detail the therapeutic application of EVs in cancer treat-ment, including their role in cancer immunotherapy and as natural delivery systems for anticancer agents including natural compounds such as paclitaxel and doxorubicin. We consider standardised protocols and proper analytical approaches to be crucial in improving the reproducibility and rigor in EV research and ensuring the successful translation of EVs as anticancer therapeutics.

学科与关键词

关键词
Extracellular vesiclesDrug deliveryNanomedicineNatural compounds
相关
加载中…
  • Harnessing the therapeutic potential of extracellular vesicles for cancer treatment
    Zhang, Ying; Xiao, Yu; Sun, Gaoge; Jin, Xue; Guo, Lerui; Li, Tian; Yin, Hang*Seminars in Cancer Biology, 2021, 74: 92-104.被引 7
  • Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance
    Chen, Ming-Kun; Chen, Zi-Xian; Mao-Ping, Cai; Chen, Hong; Chen, Zhuang-Fei*; Zhao, Shan-Chao*Cancer Communications, 2024, 44(2): 205-225.被引 1
  • Engineered extracellular vesicles and their mimetics for cancer immunotherapy
    Liu, Chunping; Wang, Yichao; Li, Longmei; He, Dongyue; Chi, Jiaxin; Li, Qin; Wu, Yixiao; Zhao, Yunxuan; Zhang, Shihui; Wang, Lei*; Fan, Zhijin*; Liao, Yuhui*Journal of Controlled Release, 2022, 349: 679-698.被引 66
查看全部 →

发表信息

论文状态
公开发表
期刊
Seminars in Cancer Biology
发表日期
2022-05
卷期
第 80 卷
页码
340-355
DOI
10.1016/j.semcancer.2020.08.007
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National University of Singapore [R-184-000-295-733, R-184-000-295-133]; Hong Kong Innovation and Technology Commission [ITS/201/18]; Hong Kong Health and Medical Research Fund [06172196]

作者

  • P

    Pirisinu, Marco (第一作者)

  • T

    Tin Chanh Pham

查看全部 6 位作者收起作者
  • Z

    Zhang, Daniel Xin

  • T

    Tran Nguyen Hong

    inst med

  • L

    Lap Thi Nguyen

  • L

    Le, Minh T. N. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417